Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized high dose budesonide in acute mild-moderate asthma exacerbation
TCTR20231114003Phase 4Unknown
- Sponsor
- Panyananthaphikkhu Chonprathan Medical Center
- Start
- Sep 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide in asthma exacerbation (2 arms), sponsored by Panyananthaphikkhu Chonprathan Medical Center. Status: unknown.
02
Drugs
budesonide
03
Conditions
asthma exacerbation
Beyond the preview
Go deeper on TCTR20231114003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231114003.